Results support the development of tislelizumab in potentially synergistic combinations across Novartis advanced therapeutic platforms for the treatment of an array of solid tumours
If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe
These melas serve as platforms to attract thousands of people to avail quality healthcare services along with essential medicines and diagnostic services
The peptide-based vaccine induces a t cell-dependent response
Lilly may be eligible for up to US $ 225m in payments based upon the achievement of pre-specified development, regulatory and commercial milestones
Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting
This state-of-art technology will help pulmonologists to diagnose lung cancer in the very early stages helping the patient get an early surgical resection
This is the first CAR T cell therapy application filed for the second-line treatment of R/R LBCL in Japan
Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers
This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
Subscribe To Our Newsletter & Stay Updated
